Systematic verification of saliva-based biosignatures for oral cancer via targeted metabolomics
Journal of Food and Drug Analysis · 06.07.2026 · 34 (1)
DOI: 10.38212/2224-6614.3586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 06.07.2026. Verfasst von Ya-Ju Hsieh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Saliva, Metabolomics, Biomarkers, Tumor. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) remains a major global health challenge, and early detection is essential for improving patient outcomes. To identify reliable salivary biomarkers, we performed a targeted metabolomics study using 13C2/12C2-dansylation, integrating candidate metabolites from published OSCC metabolomics datasets and systematically verifying them through LC-MRM-MS. A panel of 26 metabolites was quantified in saliva samples from 299 subjects, including healthy controls (n = 98), oral potentially malignant disorders (OPMD I, n = 50; OPMD II, n = 53), and OSCC patients (n = 98). Among these, cadaverine, N-acetylcadaverine, choline, glycine, and tryptophan were significantly dysregulated across disease groups. Cadaverine, N-acetylcadaverine and choline were consistently elevated in OSCC and showed progressive increases with disease stages, whereas glycine levels declined. A four-metabolite panel (cadaverine, N-acetylcadaverine, choline, glycine) demonstrated strong diagnostic performance in distinguishing OSCC from healthy controls (AUC = 0.91). Correlation analyses further revealed coordinated regulation among polyamine-related metabolites, suggesting a reprogramming of ornithine–polyamine metabolism in OSCC progression. In conclusion, we establish a verified salivary metabolite panel with high discriminatory power for OSCC detection. These findings highlight polyamine-associated metabolic alterations as a hallmark of malignant transformation in the oral cavity and support salivary metabolomics as a clinically accessible tool for non-invasive screening and risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Otolaryngology-Head & Neck Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Biomedical Sciences, Chang Gung University, Taoyuan 33302, Taiwan.
- Kidney Research Center, Department of Nephrology, LinKou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Zitieren
APA
Hsieh, Y. J., Chang, Y., Yang, C., Teng, N. H., Yu, J. S., Chang, K. P., Chen, W. C., Chu, L. J., & Chen, Y. T. (2026). Systematic verification of saliva-based biosignatures for oral cancer via targeted metabolomics. Journal of Food and Drug Analysis, 34(1). https://doi.org/10.38212/2224-6614.3586
Vancouver
Hsieh YJ, Chang Y, Yang C, Teng NH, Yu JS, Chang KP, et al. Systematic verification of saliva-based biosignatures for oral cancer via targeted metabolomics. Journal of Food and Drug Analysis. 2026;34(1). doi:10.38212/2224-6614.3586
BibTeX
@article{Hsieh2026,
author = {Hsieh, Ya-Ju and Chang, Yu and Yang, Chi and Teng, Nai-Hsuan and Yu, Jau-Song and Chang, Kai-Ping and Chen, Wen-Chen and Chu, Lichieh Julie and Chen, Yi-Ting},
title = {Systematic verification of saliva-based biosignatures for oral cancer via targeted metabolomics},
journal = {Journal of Food and Drug Analysis},
year = {2026},
volume = {34},
number = {1},
doi = {10.38212/2224-6614.3586}
}
EUVIMED